Thomas H. Robinson
Founder at RobinsonButler
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Teper | M | 64 |
Cytovia Holdings, Inc.
Vector Therapeutics, Inc.
 Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Gilles Seydoux | M | - |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Armin V. Rath | M | - |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Michael Friedman | M | 80 |
Cytovia Holdings, Inc.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Laurent Audoly | M | - |
Cytovia Holdings, Inc.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Mary Moynihan | F | 57 | 27 years | |
| Susan S. Boren | F | 76 |
Spencer Stuart, Inc.
 Spencer Stuart, Inc. Personnel ServicesCommercial Services Spencer Stuart, Inc. provides leadership consulting and executive search services. The firm’s serves industries under the categories of technology, media & telecommunications, consumer, financial services, education, nonprofit & government, healthcare and industrial. It also offers corporate governance and board member recruitment services. The company was founded by Spencer R. Stuart in 1956 and is headquartered in Chicago, IL. | 26 years |
| Jason Jing Chen | M | 62 | 6 years | |
| Jason Aryeh | M | 55 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY.
Cytovia Holdings, Inc.
| 3 years |
| Anna Baran-Djokovic | F | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Alexander Mencik | M | 55 |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY. | - |
| Daniel Brennan | M | 58 | 28 years | |
| James Shmerling | M | 69 | 6 years | |
| Stanley Frankel | M | 65 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 years |
| Olivier Gouédard | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 years |
| Yumiko Murakami | F | 59 |
Harvard Business School
| 9 years |
| Michael Jones | M | - | 29 years | |
| Shikhar Ghosh | M | 66 |
Harvard Business School
| 16 years |
| Arthur Butcher | M | 53 | 28 years | |
| William Fodor | M | 65 | 7 years | |
| Rebecca M. Henderson | M | 63 |
Harvard Business School
| 15 years |
| Iulian Cioanta | M | 60 | 17 years | |
| Peter Stegagno | M | 63 | 18 years | |
| Joseph Fuller | M | 67 |
Harvard Business School
| 12 years |
| Leonard Schlesinger | M | 71 |
Harvard Business School
| 11 years |
| Eric Francis Thepaut | M | 62 | 28 years | |
| Jeffrey Mirviss | M | 58 | 27 years | |
| Lynn Sharp Paine | M | 75 |
Harvard Business School
| 14 years |
| William Kirby | M | 72 |
Harvard Business School
| 16 years |
| Kaouthar Lbiati | M | 45 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy W. Baker | M | 63 | 12 years | |
| David Green | M | 59 | 4 years | |
| Stephen J. Webber | M | 54 | 1 years | |
| Lisa Sundstrom | F | 54 | - | |
| James J. McGorry | M | 67 | 7 years | |
| Jean Fitterer Lance | F | 62 | - | |
| William Hank Kucheman | M | 74 | 16 years | |
| John F. Kennedy | M | 75 | 6 years | |
| Saurabh Agarwal | M | 43 |
Harvard Business School
| 2 years |
| Barry J. Jenkins | M | 61 | 6 years | |
| Christopher M. Cashman | M | 56 | 3 years | |
| Somerdy Harry | M | - |
Spencer Stuart, Inc.
Spencer Stuart, Inc. Personnel ServicesCommercial Services Spencer Stuart, Inc. provides leadership consulting and executive search services. The firm’s serves industries under the categories of technology, media & telecommunications, consumer, financial services, education, nonprofit & government, healthcare and industrial. It also offers corporate governance and board member recruitment services. The company was founded by Spencer R. Stuart in 1956 and is headquartered in Chicago, IL. | 11 years |
| Brian M. Barefoot | M | 81 | 6 years | |
| Ettore Victor Biagioni | M | 66 | 12 years | |
| Karleen Oberton | F | 54 | - | |
| Saverio la Francesca | M | 62 | 3 years | |
| Bernard Laurel | M | - | - | |
| Patricia K. Dolan | F | - | - | |
| Arthur Rosenthal | M | 77 | 11 years | |
| Rehito Hatoyama | M | 50 |
Harvard Business School
| 2 years |
| Milton Morris | M | 54 | 11 years | |
| Eric Engineer | M | - |
Harvard Business School
| 2 years |
| Blaine McKee | M | 59 | 2 years | |
| William O. Flannery | M | 78 | 13 years | |
| Peter Anastos | M | 62 | 3 years | |
| Michael Sherman | M | - |
Harvard Business School
| 2 years |
| John B. Pedersen | M | 61 | - | |
| John Fritzen Nemelka | M | 59 | 13 years | |
| Lawrence R. Neumann | M | 61 | - | |
| Ronald Sparks | M | 69 | 1 years | |
| John J. Canepa | M | 68 | 5 years | |
| Michael Berman | M | 66 | 5 years | |
| Elana Berkowitz | F | - |
Harvard Business School
| - |
| Alex Western | M | - |
Harvard Business School
| 2 years |
| Joseph P. Caruso | M | 65 | - | |
| Barbara Henagan | F | 64 | 1 years | |
| Paul W. Sandman | M | 76 | 15 years | |
| David W. McFaul | M | 67 | - | |
| Rory Verret | M | - |
Spencer Stuart, Inc.
Spencer Stuart, Inc. Personnel ServicesCommercial Services Spencer Stuart, Inc. provides leadership consulting and executive search services. The firm’s serves industries under the categories of technology, media & telecommunications, consumer, financial services, education, nonprofit & government, healthcare and industrial. It also offers corporate governance and board member recruitment services. The company was founded by Spencer R. Stuart in 1956 and is headquartered in Chicago, IL. | 4 years |
| Marina I. Hatsopoulos | F | 58 | 9 years | |
| Rahul Anne | M | - |
Harvard Business School
| 2 years |
| Badge Stone | M | - |
Harvard Business School
| 2 years |
| Abdul Aziz Ibraheem Mohammed Al-Essa | M | - |
Harvard Business School
| 4 years |
| Charles J. Burns | M | 38 |
Harvard Business School
| 2 years |
| Katherine Ireland | F | - |
Harvard Business School
| 3 years |
| David Schultz | M | - | 3 years | |
| Ravi Umarji | M | - |
Harvard Business School
| 2 years |
| Randel Richner | F | 68 | 9 years | |
| Patricia Kennedy | F | 63 | 5 years | |
| Daniel Settel | M | - |
Harvard Business School
| 2 years |
| Edward Northup | M | 75 | - | |
| Paul LaViolette | M | 66 | 14 years | |
| Richard Carona | M | - |
Harvard Business School
| 2 years |
| Sam W. Spirn | M | - |
Harvard Business School
| 2 years |
| Arthur O. McGill | M | - |
Harvard Business School
| 2 years |
| Alex Crisses | M | - |
Harvard Business School
| 2 years |
| Brad Buser | M | - |
Harvard Business School
| 2 years |
| Rytis Vitkauskas | M | 40 |
Harvard Business School
| 2 years |
| Gustavo A. Herrero | M | 76 |
Harvard Business School
| 14 years |
| Dara Leung | F | - |
Harvard Business School
| 2 years |
| Blake L. Gottesman | M | - |
Harvard Business School
| 2 years |
| Robert G. MacLean | M | 80 | - | |
| René Spaargaren | M | - | 7 years | |
| Miguel Crivelli | M | - |
Harvard Business School
| 2 years |
| David Gyorke | M | 64 | 6 years | |
| Nicholas J. Nicholas | M | 83 | 22 years | |
| Payal Divakaran | F | - |
Harvard Business School
| 2 years |
| Nathaniel Fick | M | 46 |
Harvard Business School
| 2 years |
| Maria Palasis | M | 59 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas H. Robinson
- Personal Network
